Helicobacter pylori and Nonmalignant Diseases

Helicobacter

Volumn 17, Issue SUPPL.1, 2012, Pages 22-25

  Shmuely, Haim ^a,b   Katicic, Miroslava ^c   Filipec Kanizaj, Tajana ^c   Niv, Yaron ^a,b  

^a RABIN MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

^c University of Zagreb   (Croatia)

Author keywords

Functional dyspepsia; Gastroesophageal reflux disease; Peptic ulcer disease

Indexed keywords

ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; PROTON PUMP INHIBITOR; STOMACH SECRETION INHIBITOR;

ANTIBIOTIC THERAPY; CLINICAL DECISION MAKING; CONSENSUS; DISEASE ASSOCIATION; DISEASE CONTROL; DISEASE SEVERITY; DUODENAL ULCER BLEEDING; DUODENUM ULCER; DYSPEPSIA; GASTROESOPHAGEAL REFLUX; GASTROINTESTINAL ENDOSCOPY; GASTROINTESTINAL SYMPTOM; HELICOBACTER INFECTION; HUMAN; INCIDENCE; MORTALITY; PEPTIC ULCER; PREVALENCE; PRIORITY JOURNAL; QUALITY OF LIFE; REFLUX ESOPHAGITIS; REVIEW; RISK ASSESSMENT; SEROLOGY; SEX DIFFERENCE; STOMACH ULCER;

ANIMALS; ANTI-BACTERIAL AGENTS; GASTROINTESTINAL AGENTS; GASTROINTESTINAL DISEASES; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS;

HELICOBACTER; HELICOBACTER PYLORI;

EID: 84866145385     PISSN: 10834389     EISSN: 15235378     Source Type: Journal    
DOI: 10.1111/j.1523-5378.2012.00978.x     Document Type: Review

References (21)

1. Sonnenberg A, Lash RH, Genta RM. A national study of Helicobacter pylori infection in gastric biopsy specimens. Gastroenterology. 2010;139:1894-1901.
2. Katicic M, Filipec Kanizaj T, Mrzljak A, Skurla B, Prskalo M, Sobocan N, et al. The decline in prevalence of H. pylori infection in Croatia affect significantly the incidence of esofago-gastro-duodenal (EGD) endoscopic findings. Helicobacter 2011;16(Suppl 1):105.
3. Zelickson MS, Bronder CM, Johnson BL, Camunas JA, Smith DE, Rawlinson D, et al. Helicobacter pylori is not the predominant etiology for peptic ulcers requiring operation. Am Surg 2011;77:1054-60.
4. Kang JM, Kim N, Lee BH, Park HK, Jo HJ, Shin CM, et al. Risk factors for peptic ulcer bleeding in terms of Helicobacter pylori, NSAIDs, and antiplatelet agents. Scand J Gastroenterol 2011;46:1295-301.
5. Lanza FL, Chan FK, Quigley EM. Guidelines for prevention of NSAID-related ulcer complications. Am J Gastroenterol 2009;104:728-38.
6. Vergara M, Catalan M, Gisbert JP, Calvet X. Meta-analysis: role of Helicobacter pylori eradication in the prevention of peptic ulcer in NSAID users. Aliment Pharmacol Ther 2005;21:1411-8.
7. Manguso F, Riccio E, Nucci G, Aiezza ML, Amato G, Degl'Innocenti L, et al. Helicobacter pylori infection in bleeding peptic ulcer patients after non-steroidal anti-inflammatory drug consumption. World J Gastroenterol 2011;28:4509-16.
8. Tomtitchong P, Siribumrungwong B, Vilaichone RK, Kasetsuwan P, Matsukura N, Chaiyakunapruk N. Systematic review and meta-analysis: Helicobacter pylori eradication therapy after simple closure of perforated duodenal ulcer. Helicobacter 2012;17:148-52.
9. Malfertheiner P, Megraud F, O'Morain C, Bazzoli F, El-Omar E, Graham D, et al. Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report. Gut 2007;56:772-81.
10. Malfertheiner P, Megraud F, O'Morain CA, Atherton J, Axon ATR, Bazzoli F, et al. Management of Helicobacter pylori infection the Maastricht IV/Florence Consensus Report. Gut 2012;61:646-64.
11. Miwa H, Ghoshal UC, Fock KM, Gonlachanvit S, Gwee KA, Ang TL, et al. Asian consensus report on functional dyspepsia. J Gastroenterol Hepatol 2012;27:626-41.
12. Kachintorn U. Epidemiology, approach and management of functional dyspepsia in Thailand. J Gastroenterol Hepatol 2011;3:32-4.
13. Fock KM. Functional dyspepsia, H. pylori and post infectious FD. J Gastroenterol Hepatol 2011;3:39-41.
14. Mazzoleni LE, Sander GB, Francesconi CF, Mazzoleni F, Uchoa DM, De Bona LR, et al. Helicobacter pylori eradication in functional dyspepsia: HEROES trial. Arch Intern Med 2011;28:1929-36.
15. Lan L, Yu J, Chen YL, Zhong YL, Zhang H, Jia CH, et al. Symptom- based tendencies of Helicobacter pylori eradication in patients with functional dyspepsia. World J Gastroenterol 2011;21:3242-7.
16. Mirbagheri SA, Khajavirad N, Rakhshani N, Ostovaneh MR, Hoseini SM, Hoseini V. Impact of Helicobacter pylori infection and microscopic duodenal histopathological changes on clinical symptoms of patients with functional dyspepsia. Dig Dis Sci 2012;57:967-72.
17. Wang PC, Hsu CS, Tseng TC, Hsieh TC, Chen CH, Su WC, et al. Male sex, hiatus hernia, and Helicobacter pylori infection associated with asymptomatic erosive esophagitis. J Gastroenterol Hepatol 2012;27:586-91.
18. Chung SJ, Lim SH, Choi J, Kim D, Kim YS, Park MJ, et al. Helicobacter pylori serology inversely correlated with the risk and severity of reflux esophagitis in Helicobacter pylori endemic area: a matched case-control study of 5, 616 health check-up Koreans. J Neurogastroenterol Motil 2011;17:267-73.
19. Kim N, Lee SW, Kim JI, Baik GH, Kim SJ, Seo GS, et al. Effect of Helicobacter pylori eradication on the development of reflux esophagitis and gastroesophageal reflux symptoms: a nationwide multi-center prospective study. Gut Liver 2011;5:437-46.
20. Qian B, Shijie M, Shang L, Qian J, Zhang G. Effect of H. pylori eradication on gastroesophageal reflux disease. Helicobacter 2011;16:255-65.
21. Saad AM, Choudhary A, Bechtold ML. Effect of Helicobacter pylori treatment on gastroesophageal reflux disease (GERD): meta-analysis of randomized controlled trials. Scand J Gastroenterol 2012;47:129-35.